Why is BSX down?
Up 5.6% today, while its medical device peers are down 0.3%; no story names it yet.
Fell on Oct 28
Down 6% on Oct 28, and still 7% under its Oct 27 close.
- Its Oct 28 results:
BSX's Quality Score fell 1 point on Mon, Nov 2, to 0.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 5.6% today, while its medical device peers are down 0.3%; no story names it yet.
Fell on Oct 28
Down 6% on Oct 28, and still 7% under its Oct 27 close.
| Holding it back | Below its 200-day since January |
| Latest filing | 8-K, Oct 28 |
TodayNo story names it yet.
Wed Nov 11: Stifel Healthcare Conference 2026Investor conference · date confirmed.
After its last 4 reports it closed -3.6% on average, higher 1 of 4 times.
Below Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means
Well below its recent run. BSX scores 0 today, against a median of 6 over its last 20 recorded sessions.
BSX is #68 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 68 |
Net income over four quarters: BSX $3.67B, MDT $5.23B, PEN $161M.
Expected to report Wed Feb 10, before the open (in 100 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $5.1B, 1% more than a year ago; a profit of $0.40 a share, from $0.51.
BSX's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Net sales growth, reported | about 4.25% |
Sales grew 15% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 1.1% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Oct 28, 2026 | -6.9% | -5.8% | open |
| Jul 29, 2026 | -7.4% | -0.0% | +6.6% |
| Apr 22, 2026 | +5.0% | +9.0% | -1.8% |
Sales grew in six of the last seven years, to $20B in 2025. It made a profit in seven of the eight years.
5 insiders bought $10M across 10 filings in the last 6 months. No open-market sales on record. The newest:
51 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: BSX is under 0.1% of SPYI, under 0.1% of VOO, and under 0.1% of IVV, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
“We encounter significant competition across our business segments, product lines and markets, from global and local competitors.”
BSX scores 0 today, which Breakaway calls Below Average. It is #68 of 85 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Down 6% on Oct 28, and still 7% under its Oct 27 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
BSX scores 0 today, which Breakaway calls Below Average (0 to 5). That is #68 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind BSX's 0.
5 insiders bought $10M across 10 filings in the last 6 months. No open-market sales on record. The newest is Susan E. Morano, Director, who bought $100K on Aug 25. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.